Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage-Reference-Cited by-同舟云学术

Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage

Published:2005-01 Issue:1 Volume:116 Page:55-66
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Kimmelstiel Carey,Badar Jehangir,Covic Lidija,Waxman Sergio,Weintraub Andrew,Jacques Suzanne,Kuliopulos Athan

Publisher

Elsevier BV

Subject

Hematology

Reference47 articles.

1. Local effect of serotonin released during coronary angioplasty;Golino;N. Engl. J. Med.,1994

2. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial;Ault;J. Am. Coll. Cardiol.,1999

3. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions;Karvouni;J. Am. Coll. Cardiol.,2003

4. Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? Yes;Exaire;J. Thromb. Haemost.,2004

5. Scientific and therapeutic advances in antiplatelet therapy;Bhatt;Nat. Rev., Drug Discov.,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Receptor GPR31 (G-Protein–Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis;Arteriosclerosis, Thrombosis, and Vascular Biology;2020-12-03

2. PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization;Arteriosclerosis, Thrombosis, and Vascular Biology;2020-12

3. Hereditary Disorders of Cardiovascular Calcification;Arteriosclerosis, Thrombosis, and Vascular Biology;2020-11-12

4. Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel;Thrombosis Research;2019-05

5. Electrocatalytic determination of clopidogrel using Bi2O3-Pp-AP/GCE by differential pulse voltammetry in pharmaceutical productions;Journal of Electroanalytical Chemistry;2017-11